异动解读 | 南向资金大举扫货 国药控股盘中大涨7%

异动解读
12 Nov 2024

国药控股(01099.HK)今日盘中股价大涨,一度触及7%的涨幅上限。截至发稿时间,该股报21.75港元/股,较前一交易日高开4.62%,成交量123万股,换手率0.09%。

港股通南向资金显著增仓或是推动国药控股今日大涨的重要原因。公开交易数据显示,11月11日南向资金净买入该股179.48万股,在港股通持股中占比达20.05%,持股规模仅次于腾讯控股(700.HK)和阿里巴巴(9988.HK)。资金持续涌入可能在12日开盘后助推国药控股高开高走,短线获利盘离场后,涨幅有所回落但仍维持在6%以上。

近期国药控股的基本面状况也令投资者青睐。上一财年该公司实现营收4906亿港元、净利润58亿港元,市盈率仅6.84倍。此外,63%的分析机构给予"买入"评级,看好公司长期发展前景。所处的医药分销行业整体表现也相对较佳,领涨港股多个相关板块个股。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10